Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 7, 2011, Pages 997-1008

  Hoerauf, Hans ^a   Brüggemann, Anne ^b   Muecke, Manuela ^c   Lüke, Julia ^b   Müller, Maya ^b   Stefánsson, Einar ^d   Hammes, Hans Peter ^e   Weiß, Claudia ^f  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Deutsche Bundeswehr   (Germany)

^d UNIVERSITY OF ICELAND   (Iceland)

^e UNIVERSITY OF MANNHEIM   (Germany)

^f Clinical Trials Center   (Germany)

Author keywords

Cystoid diabetic macular edema; Internal limiting membrane; Optical coherence tomography; Posterior vitreous detachment; Vitrectomy

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERNAL LIMITING MEMBRANE DELAMINATION; INTRAOPERATIVE PERIOD; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PARS PLANA VITRECTOMY; POSTERIOR HYALOID REMOVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA CYSTOID EDEMA; RETINA SURGERY; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREORETINAL SURGERY; VITREOUS BODY DETACHMENT;

AGED; BASEMENT MEMBRANE; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; IMMUNOENZYME TECHNIQUES; INDOCYANINE GREEN; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 79959691921     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-010-1610-8     Document Type: Article

References (48)

1. Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20 (2):126-133 (Pubitemid 30395706)
2. Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104(3):473-478 (Pubitemid 27120303)
3. Ikeda T, Sato K, Katano T, Hayashi Y (1999) Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol 83(1):12-14 (Pubitemid 29106323)
4. Ikeda T, Sato K, Katano T, Hayashi Y (2000) Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular dema and detached posterior hyaloid. Retina 20(2):220-222 (Pubitemid 30395725)
5. Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99(5):753-759
6. Nasrallah FP, Jalkh AE, an Coppenolle F, Kado M, Trempe CL, McMeel JW, Schepens CL (1998) The role of the vitreous in diabetic macular edema. Ophthalmology 95(10):1335-1339
7. Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, Garretson BR, Trese MT (2000) Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 130(2):178-186
8. Stefánsson E (2009) Physiology of vitreoussurgery. Graefes Arch Clin Exp Ophthalmol 247(2):147-163
9. Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG (2008) Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina 28(3):410-419 (Pubitemid 351354941)
10. Harbour JW, Smiddy WE, Flynn HW, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121(4):405-413 (Pubitemid 26113283)
11. La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ (2001) Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 239 (4):264-270 (Pubitemid 32514993)
12. Otani T, Kishi S (2002) A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol 134(2):214-219 (Pubitemid 34831825)
13. Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122(2):258-260 (Pubitemid 26271437)
14. Aboutable T, Kalvodova B (2005) Vitrektomie beim diabetischen zystoiden Makulaödem - Ergebnisse von 72 Fällen. Klin Monatsbl Augenheilkd 222:643-648 (Pubitemid 41290799)
15. Yanyali A, Horozoglu F, Celik E, Nohutcu AF (2007) Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 27(5):557-566 (Pubitemid 46905145)
16. Dillinger P, Mester U (2004) Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 242(8):630-637 (Pubitemid 39242837)
17. Recchia FM, Ruby AJ, Carvalho Recchia CA (2005) Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edemal. Am J Ophthalmol 139(3):447-454 (Pubitemid 40379070)
18. Rosenblatt BJ, Shab GK, Sharma S, Bakal J (2005) Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol 243:20-25
19. Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140:295-301
20. Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ (2006) Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 26:5-13 (Pubitemid 44391745)
21. Kaiser PK (2006) Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases. Am J Ophthalmol 142(4):660-668
22. Moher D, Schulz KF, Altman DG, Consort Group (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191-1194 (Pubitemid 32378696)
23. Early Treatment Diabetic Retinopathy Study Group (1987) Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early treatment diabetic retinopathy study report number 2. Ophthalmology 94(7):761-774
24. Stefaniotou M, Aspiotis M, Kalogeropoulos C, Christodoulou A, Psylla M, Ioachim E, Alamanos I, Psilas K (2004) Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 14:137-143 (Pubitemid 38620466)
25. Bahadir M, Ertan A, Mertoglu O (2005) Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol 26(1-2):3-8
26. Kumar A, Sinha S, Azad R, Sharma YR, Vohra R (2007) Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 245(3):360-368 (Pubitemid 46403996)
27. Hoerauf H, Wirbelauer C, Scholz C, Engelhardt R, Koch P, Laqua H, Birngruber R (2000) Slit-lamp-adapted optical coherence tomography of the anterior segment. Graefes Arch Clin Exp Ophthalmol 238(1):8-18 (Pubitemid 30160495)
28. Goebel W, Kretzchmar-Gross T (2002) Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 22(6):759-767 (Pubitemid 35462506)
29. Matsunaga N, Ozeki H, Hirabayashi Y, Shimada S, Ogura Y (2005) Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 25:311-316 (Pubitemid 40517360)
30. Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM (2004) Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 242:273-278 (Pubitemid 38647598)
31. Stefánsson E, Novack RL, Hatchell DL (1990) Vitrectomy prevents hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31:284-289 (Pubitemid 20072693)
32. Stefánsson E (2001) Therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79:435-440
33. Uckermann O, Uhlmann S, Pannicke T, Francke M, Gamsalijew R, Makarov F, Ulbricht E, Wiedemann P, Reichenbach A, Osborne NN, Bringmann A (2005) Ischemia-reperfusion causes exudative detachment of the rabbit retina. Invest Ophthalmol Vis Sci 46(7):2592-2600 (Pubitemid 43119511)
34. Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A (2005) Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 139:638-652
35. Sonada KH, Sakamoto T, Enaida H, Miyazaki M, Noda Y, Nakamura T, Ueno A, Yokoyama M, Kubota T, Ishibashi T (2004) Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 111:226-230 (Pubitemid 38183219)
36. Hanneken A, Juan E Jr, Lutty GA, Fox GM, Schiffer S, Hjelmeland LM (1991) Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol 109:1005-1011
37. Hammes HP, Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, Preissner KT (1996) Modification of vibronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest 75:325-338 (Pubitemid 26314518)
38. Hammes HP, Alt A, Niwa T, Clausen JT, Bretzel RG, Brownlee M, Schleicher ED (1992) Differential accumulation of advanced glycation endprocucts in the course of diabetic retinopathy. Diabetologica 42:728-736
39. Hammes HP, Hoerauf H, Alt A, Schleicher E, Clausen JT, Bretzel RG, Laqua H (1990) N(epision)(carboxymethyl)lysine and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci 40:1855-1859
40. Augustin AJ, Spitznas M, Koch F, Grus F, Böker T (1995) Indications of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ger J Ophthalmol 4:47-51
41. Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, Suske G, Ahmed N, Thornalley PJ, Sarthy VP, Hammes HP, Brownlee M (2006) Methylglyoxal modification of mSin3A links altered glycolysis to angiopoietin-2 transcription: A novel mechanism for regulating gene expression. Cell 124:275-286 (Pubitemid 43121977)
42. Nishikawa T, Edelstein D, Xue LD, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790 (Pubitemid 30212409)
43. Avci R, Avci B, Kaderli B, Cavusoglu I (2004) A new surgical approach for indocyanine green-assisted internal limiting membrane peeling. Ophthalmic Surg Lasers Imaging 35:292-297 (Pubitemid 39013631)
44. Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B (2006) Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema. Eur J Ophthalmol 16 (4):566-572 (Pubitemid 44859665)
45. Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M (2006) Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113(9):1533-1538 (Pubitemid 44292310)
46. Jonas JB, Kamppeter BA, Harder B, Vossmerbaeumer U, Sauder G, Spandau UH (2006) Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study. J Ocul Pharmacol Ther 22(3):200-207 (Pubitemid 44051133)
47. Cunningsham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, Goldbaum M, Guyer DR, Katz B, Patel M, Schwartz SD, Macugen Diabetic Retinopathy Study Group (2005) A phase II randomized double-masked trial of pegaptanib, an antivascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112(10):1747-1757 (Pubitemid 41400011)
48. Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26(9):999-1005 (Pubitemid 44973218)